{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:53:39Z","timestamp":1740099219099,"version":"3.37.3"},"posted":{"date-parts":[[2023,2,14]]},"group-title":"In Review","reference-count":46,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P20GM103460"],"award-info":[{"award-number":["P20GM103460"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30GM122733"],"award-info":[{"award-number":["P30GM122733"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["#1726880"],"award-info":[{"award-number":["#1726880"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011084","name":"Sigma Xi","doi-asserted-by":"publisher","award":["#G0315202198510166"],"award-info":[{"award-number":["#G0315202198510166"]}],"id":[{"id":"10.13039\/100011084","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001797","name":"Pharmaceutical Research and Manufacturers of America Foundation","doi-asserted-by":"publisher","award":["Research Starter Grant in Drug Delivery"],"award-info":[{"award-number":["Research Starter Grant in Drug Delivery"]}],"id":[{"id":"10.13039\/100001797","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,2,10]]},"abstract":"<title>Abstract<\/title>\n        <p>Delivering cargo to the central nervous system (CNS) remains a pharmacological challenge. For infectious diseases such as HIV, the CNS acts as a latent reservoir that is inadequately managed by systemic antiretrovirals (ARTs). ARTs thus cannot eradicate HIV, and given CNS infection, patients experience an array of neurological deficits that are collectively referred to as \u2018neuroHIV\u2019. Herein we report the development of bioinspired ionic liquid-coated nanoparticles (IL-NPs) for <italic>in situ<\/italic> hitchhiking on red blood cells (RBCs), which enabled 48% delivery of intravenously infused cargo to the brain. Moreover, the ionic liquid (IL) choline trans-2-hexenoate (CA2HA 1:2) demonstrated preferential accumulation in parenchymal microglia over endothelial cells post-delivery. We further demonstrate the successful loading of abacavir (ABC), an ART that is challenging to encapsulate, into the IL-coated NPs and verify the retention of antiviral efficacy <italic>in vitro.<\/italic> IL-NPs were not cytotoxic to primary human peripheral blood mononuclear cells (PBMCs) and the CA2HA 1:2 coating conferred notable anti-viremic capacity on its own. In addition, <italic>in vitro<\/italic> cell culture assays showed markedly increased uptake of IL-coated nanoparticles into neuronal cells compared to bare nanoparticles. This work debuts bioinspired ionic liquids as promising nanoparticle coatings to assist CNS biodistribution and has the potential to revolutionize the delivery of cargos (i.e., drugs, viral vectors) through compartmental barriers such as the blood-brain-barrier (BBB), illustrated in the graphical abstract below.<\/p>","DOI":"10.21203\/rs.3.rs-2574352\/v1","type":"posted-content","created":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T19:00:08Z","timestamp":1676401208000},"source":"Crossref","is-referenced-by-count":2,"title":["Ionic Liquid Coating-Driven Nanoparticle Delivery to the Brain: Applications for NeuroHIV"],"prefix":"10.21203","author":[{"given":"Christine M.","family":"Hamadani","sequence":"first","affiliation":[{"name":"University of Mississippi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fakhri","family":"Mahdi","sequence":"additional","affiliation":[{"name":"University of Mississippi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anya","family":"Merrell","sequence":"additional","affiliation":[{"name":"University of Mississippi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Flanders","sequence":"additional","affiliation":[{"name":"University of Mississippi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruofan","family":"Cao","sequence":"additional","affiliation":[{"name":"University of Mississippi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyavrat","family":"Vashisth","sequence":"additional","affiliation":[{"name":"University of Mississippi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes C.","family":"Pride","sequence":"additional","affiliation":[{"name":"University of Mississippi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alysha N.","family":"Hunter","sequence":"additional","affiliation":[{"name":"University of Mississippi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gagandeep","family":"Singh","sequence":"additional","affiliation":[{"name":"University of Mississippi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregg","family":"Roman","sequence":"additional","affiliation":[{"name":"University of Mississippi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason J.","family":"Paris","sequence":"additional","affiliation":[{"name":"University of Mississippi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7919-2249","authenticated-orcid":false,"given":"Eden E. L.","family":"Tanner","sequence":"additional","affiliation":[{"name":"University of Mississippi"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11904-015-0257-9","article-title":"The Potential of the CNS as a Reservoir for HIV-1 Infection: Implications for HIV Eradication","volume":"12","author":"Fois AF","year":"2015","unstructured":"Fois, A.F., Brew, B.J. The Potential of the CNS as a Reservoir for HIV-1 Infection: Implications for HIV Eradication. Curr HIV\/AIDS Rep 12, 299\u2013303 (2015). https:\/\/doi.org\/10.1007\/s11904-015-0257-9.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fcimb.2019.00362","article-title":"Microglial Cells: The Main HIV-1 Reservoir in the Brain","volume":"24","author":"Wallet C","unstructured":"Wallet C, De Rovere M, Van Assche J, Daouad F, De Wit S, Gautier V, Mallon PWG, Marcello A, Van Lint C, Rohr O, Schwartz C. Microglial Cells: The Main HIV-1 Reservoir in the Brain. Front Cell Infect Microbiol. 2019 Oct 24;9:362. doi: 10.3389\/fcimb.2019.00362. PMID: 31709195; PMCID: PMC6821723.","journal-title":"Front Cell Infect Microbiol. 2019 Oct"},{"issue":"543","key":"ref3","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaz0802","article-title":"Single-cell transcriptional landscapes reveal HIV-1\u2013driven aberrant host gene transcription as a potential therapeutic target","volume":"12","author":"Liu R","year":"2020","unstructured":"Liu, R., Yeh, Y., Varabyou, A., Collora, J., Sherrill-Mix, S., & Talbot, C. et al. (2020). Single-cell transcriptional landscapes reveal HIV-1\u2013driven aberrant host gene transcription as a potential therapeutic target. Science Translational Medicine, 12(543). doi: 10.1126\/scitranslmed.aaz0802","journal-title":"Science Translational Medicine"},{"year":"1997","author":"Chun T-W","key":"ref4","unstructured":"T.-W. Chun, L. Stuyver, S. B. Mizell, L. A. Ehler, J. A. Mican, M. Baseler, A. L. Lloyd, M. A. Nowak, A. S. Fauci, Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. U.S.A. 94, 13193\u201313197 (1997)."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.chom.2019.08.003","article-title":"HIV rebound is predominantly fueled by genetically identical viral expansions from diverse reservoirs","volume":"26","author":"Scheerder M-A","year":"2019","unstructured":"M.-A. De Scheerder, B. Vrancken, S. Dellicour, T. Schlub, E. Lee, W. Shao, S. Rutsaert, C. Verhofstede, T. Kerre, T. Malfait, D. Hemelsoet, M. Coppens, A. Dhondt, D. De Looze, F. Vermassen, P. Lemey, S. Palmer, L. Vandekerckhove, HIV rebound is predominantly fueled by genetically identical viral expansions from diverse reservoirs. Cell Host Microbe 26, 347\u2013358.e7 (2019).","journal-title":"Cell Host Microbe"},{"issue":"6","key":"ref6","doi-asserted-by":"publisher","first-page":"e1008381","DOI":"10.1371\/journal.ppat.1008381","article-title":"HIV infects astrocytes in vivo and egresses from the brain to the periphery","volume":"11","author":"Lutgen V","unstructured":"Lutgen V, Narasipura SD, Barbian HJ, Richards M, Wallace J, Razmpour R, Buzhdygan T, Ramirez SH, Prevedel L, Eugenin EA, Al-Harthi L. HIV infects astrocytes in vivo and egresses from the brain to the periphery. PLoS Pathog. 2020 Jun 11;16(6):e1008381. doi: 10.1371\/journal.ppat.1008381. PMID: 32525948; PMCID: PMC7289344.","journal-title":"PLoS Pathog. 2020 Jun"},{"issue":"2","key":"ref7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/jnc.15336","article-title":"Astrocytes are HIV reservoirs in the brain: A cell type with poor HIV infectivity and replication but efficient cell-to-cell viral transfer","volume":"158","author":"Valdebenito S","year":"2021","unstructured":"Valdebenito S, Castellano P, Ajasin D, Eugenin EA. Astrocytes are HIV reservoirs in the brain: A cell type with poor HIV infectivity and replication but efficient cell-to-cell viral transfer. J Neurochem. 2021 Jul;158(2):429\u2013443. doi: 10.1111\/jnc.15336. Epub 2021 Mar 22. PMID: 33655498.","journal-title":"J Neurochem"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"867","DOI":"10.3390\/vaccines9080867","article-title":"HIV in the Brain: Identifying Viral Reservoirs and Addressing the Challenges of an HIV Cure","volume":"9","author":"Ash MK","year":"2021","unstructured":"Ash, M.K.; Al-Harthi, L.; Schneider, J.R. HIV in the Brain: Identifying Viral Reservoirs and Addressing the Challenges of an HIV Cure. Vaccines 2021, 9, 867. https:\/\/doi.org\/10.3390\/vaccines9080867.","journal-title":"Vaccines"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s11481-018-9809-2","article-title":"Macrophages but not Astrocytes Harbor HIV DNA in the Brains of HIV-1-Infected Aviremic Individuals on Suppressive Antiretroviral Therapy","volume":"14","author":"Ko A","year":"2019","unstructured":"Ko, A., Kang, G., Hattler, J.B. et al. Macrophages but not Astrocytes Harbor HIV DNA in the Brains of HIV-1-Infected Aviremic Individuals on Suppressive Antiretroviral Therapy. J Neuroimmune Pharmacol 14, 110\u2013119 (2019). https:\/\/doi.org\/10.1007\/s11481-018-9809-2.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1","key":"ref10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12977-017-0370-5","article-title":"Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain","volume":"16","author":"Asahchop EL","unstructured":"Asahchop EL, Meziane O, Mamik MK, Chan WF, Branton WG, Resch L, Gill MJ, Haddad E, Guimond JV, Wainberg MA, Baker GB, Cohen EA, Power C. Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain. Retrovirology. 2017 Oct 16;14(1):47. doi: 10.1186\/s12977-017-0370-5. PMID: 29037245; PMCID: PMC5644262.","journal-title":"Retrovirology. 2017 Oct"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/COH.0000000000000287","article-title":"Persistent HIV-1 replication during antiretroviral therapy","volume":"11","author":"Martinez-Picado J","year":"2016","unstructured":"Martinez-Picado J, Deeks SG (2016) Persistent HIV-1 replication during antiretroviral therapy. Curr Opin HIV AIDS 11:417\u2013423","journal-title":"Curr Opin HIV AIDS"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s11481-019-09858-x","article-title":"Cerebral Vascular Toxicity of Antiretroviral Therapy","volume":"16","author":"Bertrand L","year":"2021","unstructured":"Bertrand, L., Velichkovska, M. & Toborek, M. Cerebral Vascular Toxicity of Antiretroviral Therapy. J Neuroimmune Pharmacol 16, 74\u201389 (2021). https:\/\/doi.org\/10.1007\/s11481-019-09858-x","journal-title":"J Neuroimmune Pharmacol"},{"issue":"9","key":"ref13","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.tins.2020.06.007","article-title":"The Paradox of HIV Blood-Brain Barrier Penetrance and Antiretroviral Drug Delivery Deficiencies","volume":"43","author":"Osborne O","year":"2020","unstructured":"Osborne O, Peyravian N, Nair M, Daunert S, Toborek M. The Paradox of HIV Blood-Brain Barrier Penetrance and Antiretroviral Drug Delivery Deficiencies. Trends Neurosci. 2020 Sep;43(9):695\u2013708. doi: 10.1016\/j.tins.2020.06.007. Epub 2020 Jul 15. PMID: 32682564; PMCID: PMC7483662.","journal-title":"Trends Neurosci"},{"key":"ref14","first-page":"134475","article-title":"Cell-type specific differences in antiretroviral penetration and the effects of HIV-1 Tat and morphine among primary human brain endothelial cells, astrocytes, pericytes, and microglia","volume":"1","author":"Patel SH","unstructured":"Patel SH, Ismaiel OA, Mylott WR Jr, Yuan M, McClay JL, Paris JJ, Hauser KF, McRae M. Cell-type specific differences in antiretroviral penetration and the effects of HIV-1 Tat and morphine among primary human brain endothelial cells, astrocytes, pericytes, and microglia. Neurosci Lett. 2019 Nov 1;712:134475. doi: 10.1016\/j.neulet.2019.134475. Epub 2019 Sep 3. PMID: 31491466; PMCID: PMC6941658.","journal-title":"Neurosci Lett. 2019 Nov"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.17.4.942-964.2004","author":"Rock RB","year":"2004","unstructured":"Rock RB, Gekker G, Hu S, Sheng WS, Cheeran M, Lokensgard JR, Peterson PK. Role of microglia in central nervous system infections. Clin Microbiol Rev. 2004 Oct;17(4):942 \u2013 64, table of contents. doi: 10.1128\/CMR.17.4.942-964.2004. PMID: 15489356; PMCID: PMC523558."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev.neuro.25.112701.142822","article-title":"Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS","volume":"25","author":"Williams KC","year":"2002","unstructured":"Williams, K. C., and W. F. Hickey. 2002. Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu. Rev. Neurosci. 25:537\u2013562.","journal-title":"Annu. Rev. Neurosci."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fcimb.2019.00069","article-title":"Application of CRISPR\/Cas9-Based Gene Editing in HIV-1\/AIDS Therapy","volume":"22","author":"Xiao Q","unstructured":"Xiao Q, Guo D, Chen S. Application of CRISPR\/Cas9-Based Gene Editing in HIV-1\/AIDS Therapy. Front Cell Infect Microbiol. 2019 Mar 22;9:69. doi: 10.3389\/fcimb.2019.00069. PMID: 30968001; PMCID: PMC6439341.","journal-title":"Front Cell Infect Microbiol. 2019 Mar"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1038\/s41467-019-10366-y","article-title":"Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice","volume":"10","author":"Dash PK","year":"2019","unstructured":"Dash, P.K., Kaminski, R., Bella, R. et al. Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice. Nat Commun 10, 2753 (2019). https:\/\/doi.org\/10.1038\/s41467-019-10366-y","journal-title":"Nat Commun"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41467-021-27647-0","article-title":"Latency reversal plus natural killer cells diminish HIV reservoir in vivo","volume":"13","author":"Kim JT","year":"2022","unstructured":"Kim, J.T., Zhang, TH., Carmona, C. et al. Latency reversal plus natural killer cells diminish HIV reservoir in vivo. Nat Commun 13, 121 (2022). https:\/\/doi.org\/10.1038\/s41467-021-27647-0.","journal-title":"Nat Commun"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12977-021-00581-1","article-title":"Editing out HIV: application of gene editing technology to achieve functional cure","volume":"18","author":"Xun J","year":"2021","unstructured":"Xun, J., Zhang, X., Guo, S. et al. Editing out HIV: application of gene editing technology to achieve functional cure. Retrovirology 18, 39 (2021). https:\/\/doi.org\/10.1186\/s12977-021-00581-1.","journal-title":"Retrovirology"},{"issue":"13","key":"ref21","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.1021\/acs.chemrev.9b00693","article-title":"Microstructural and Dynamical Heterogeneities in Ionic Liquids","volume":"8","author":"Wang YL","unstructured":"Wang YL, Li B, Sarman S, Mocci F, Lu ZY, Yuan J, Laaksonen A, Fayer MD. Microstructural and Dynamical Heterogeneities in Ionic Liquids. Chem Rev. 2020 Jul 8;120(13):5798\u20135877. doi: 10.1021\/acs.chemrev.9b00693. Epub 2020 Apr 15. PMID: 32292036; PMCID: PMC7349628.","journal-title":"Chem Rev. 2020 Jul"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jconrel.2018.07.029","article-title":"Transdermal insulin delivery using choline-based ionic liquids (CAGE)","volume":"28","author":"Tanner EEL","unstructured":"Tanner EEL, Ibsen KN, Mitragotri S. Transdermal insulin delivery using choline-based ionic liquids (CAGE). J Control Release. 2018 Sep 28;286:137\u2013144. doi: 10.1016\/j.jconrel.2018.07.029. Epub 2018 Jul 17. PMID: 30026081.","journal-title":"J Control Release. 2018 Sep"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jconrel.2020.07.037","article-title":"Ionic liquid-mediated delivery of insulin to buccal mucosa","volume":"10","author":"Vaidya A","unstructured":"Vaidya A, Mitragotri S. Ionic liquid-mediated delivery of insulin to buccal mucosa. J Control Release. 2020 Nov 10;327:26\u201334. doi: 10.1016\/j.jconrel.2020.07.037. Epub 2020 Jul 29. PMID: 32735879.","journal-title":"J Control Release. 2020 Nov"},{"issue":"50","key":"ref24","doi-asserted-by":"publisher","first-page":"25042","DOI":"10.1073\/pnas.1914426116","article-title":"Oral ionic liquid for the treatment of diet-induced obesity","volume":"10","author":"Nurunnabi M","unstructured":"Nurunnabi M, Ibsen KN, Tanner EEL, Mitragotri S. Oral ionic liquid for the treatment of diet-induced obesity. Proc Natl Acad Sci U S A. 2019 Dec 10;116(50):25042\u201325047. doi: 10.1073\/pnas.1914426116. Epub 2019 Nov 25. PMID: 31767747; PMCID: PMC6911186.","journal-title":"Proc Natl Acad Sci U S A. 2019 Dec"},{"issue":"17","key":"ref25","doi-asserted-by":"publisher","first-page":"e2004819","DOI":"10.1002\/advs.202004819","article-title":"Recent Advances in Ionic Liquids in Biomedicine. Adv Sci (Weinh)","volume":"8","author":"Curreri AM","year":"2021","unstructured":"Curreri AM, Mitragotri S, Tanner EEL. Recent Advances in Ionic Liquids in Biomedicine. Adv Sci (Weinh). 2021 Sep;8(17):e2004819. doi: 10.1002\/advs.202004819. Epub 2021 Jul 10. PMID: 34245140; PMCID: PMC8425867."},{"author":"Hamadani CM","key":"ref26","doi-asserted-by":"publisher","unstructured":"Hamadani CM, Goetz MJ, Mitragotri S, Tanner EEL. Protein-avoidant ionic liquid (PAIL)-coated nanoparticles to increase bloodstream circulation and drive biodistribution. Sci Adv. 2020 Nov 25;6(48):eabd7563. doi: 10.1126\/sciadv.abd7563. PMID: 33239302; PMCID: PMC7688330.","DOI":"10.1126\/sciadv.abd7563"},{"issue":"16","key":"ref27","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1039\/D2NR00538G","article-title":"Improved nanoformulation and bio-functionalization of linear-dendritic block copolymers with biocompatible ionic liquids","volume":"14","author":"Hamadani CM","year":"2022","unstructured":"Hamadani, C.M., Chandrasiri, I., Yaddehige, M.L., Dasanayake, G.S., Owolabi, I., Flynt, A., Hossain, M., Liberman, L., Lodge, T.P., Werfel, T.A., Watkins, D.L., and Tanner, E.E.L., 2022. Improved nanoformulation and bio-functionalization of linear-dendritic block copolymers with biocompatible ionic liquids. Nanoscale, 14(16), pp.6021\u20136036.","journal-title":"Nanoscale"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1038\/s41467-018-05079-7","article-title":"Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude","volume":"9","author":"Brenner JS","year":"2018","unstructured":"Brenner, J.S., Pan, D.C., Myerson, J.W. et al. Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude. Nat Commun 9, 2684 (2018). https:\/\/doi.org\/10.1038\/s41467-018-05079-7.","journal-title":"Nat Commun"},{"author":"Glassman PM","key":"ref29","doi-asserted-by":"publisher","unstructured":"Glassman PM, Villa CH, Ukidve A, Zhao Z, Smith P, Mitragotri S, Russell AJ, Brenner JS, Muzykantov VR. Vascular Drug Delivery Using Carrier Red Blood Cells: Focus on RBC Surface Loading and Pharmacokinetics. Pharmaceutics. 2020 May 9;12(5):440. doi: 10.3390\/pharmaceutics12050440. PMID: 32397513; PMCID: PMC7284780.","DOI":"10.3390\/pharmaceutics12050440"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1021\/nn404853z","author":"Anselmo AC","year":"2013","unstructured":"Anselmo AC, Gupta V, Zern BJ, Pan D, Zakrewsky M, Muzykantov V, Mitragotri S. Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells. ACS Nano. 2013 Dec 23;7(12):11129-37. doi: 10.1021\/nn404853z. Epub 2013 Nov 12. PMID: 24182189; PMCID: PMC4128963."},{"author":"Zhao Z","key":"ref31","doi-asserted-by":"publisher","unstructured":"Zhao Z, Ukidve A, Gao Y, Kim J, Mitragotri S. Erythrocyte leveraged chemotherapy (ELeCt): Nanoparticle assembly on erythrocyte surface to combat lung metastasis. Sci Adv. 2019 Nov 13;5(11):eaax9250. doi: 10.1126\/sciadv.aax9250. PMID: 31763454; PMCID: PMC6853768.","DOI":"10.1126\/sciadv.aax9250"},{"issue":"3","key":"ref32","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s13365-014-0291-1","article-title":"Eradication of human immunodeficiency virus from brain reservoirs","volume":"21","author":"Nath A","year":"2015","unstructured":"Nath A. Eradication of human immunodeficiency virus from brain reservoirs. J Neurovirol. 2015 Jun;21(3):227\u201334. doi: 10.1007\/s13365-014-0291-1. Epub 2014 Nov 4. PMID: 25366659; PMCID: PMC4418952.","journal-title":"J Neurovirol"},{"author":"Palanisamy K","key":"ref33","doi-asserted-by":"publisher","unstructured":"Palanisamy K, Rubavathy SME, Prakash M, Thilagavathi R, Hosseini-Zare MS, Selvam C. Antiviral activities of natural compounds and ionic liquids to inhibit the Mpro of SARS-CoV-2: a computational approach. RSC Adv. 2022 Jan 28;12(6):3687\u20133695. doi: 10.1039\/d1ra08604a. PMID: 35425367; PMCID: PMC8979281.","DOI":"10.1039\/d1ra08604a"},{"author":"Moshikur RM","key":"ref34","doi-asserted-by":"publisher","unstructured":"Moshikur RM, Ali MK, Wakabayashi R, Moniruzzaman M, Goto M. Favipiravir-Based Ionic Liquids as Potent Antiviral Drugs for Oral Delivery: Synthesis, Solubility, and Pharmacokinetic Evaluation. Mol Pharm. 2021 Aug 2;18(8):3108\u20133115. doi: 10.1021\/acs.molpharmaceut.1c00324. Epub 2021 Jul 10. PMID: 34250805.","DOI":"10.1021\/acs.molpharmaceut.1c00324"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"10119","DOI":"10.1039\/c2cp41625e","article-title":"Enhanced stabilization of the Tobacco mosaic virus using protic ionic liquids,\"","volume":"14","author":"Byrne N","year":"2012","unstructured":"Byrne, N., Rodoni, B., Constable, F., Varghese, S. & Davis, J. H., \"Enhanced stabilization of the Tobacco mosaic virus using protic ionic liquids,\" Phys. Chem. Chem. Phys. 14, 10119\u201310121 (2012). DOI: 10.1039\/c2cp41625e.","journal-title":"Phys. Chem. Chem. Phys."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.seppur.2015.03.035","article-title":"The use of ionic liquids for cracking viruses for isolation of nucleic acids","volume":"155","author":"Fister S","year":"2015","unstructured":"Fister, S., Fuchs, S., Mester, P., Kilpel\u00e4inen, I., Wagner, M. & Rossmanith, P., \"The use of ionic liquids for cracking viruses for isolation of nucleic acids,\" Sep. Purif. Technol. 155, 38\u201344 (2015). DOI: 10.1016\/j.seppur.2015.03.035.","journal-title":"Sep. Purif. Technol."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.3389\/fmicb.2017.01608","article-title":"\"Virucidal Influence of Ionic Liquids on Phages P100 and MS2,\"","volume":"8","author":"Fister S","year":"2017","unstructured":"Fister, S., Mester, P., Sommer, J., Witte, A. K., Kalb, R., Wagner, M. & Rossmanith, P., \"Virucidal Influence of Ionic Liquids on Phages P100 and MS2,\" Front. Microbiol. 8, 1608 (2017). DOI: 10.3389\/fmicb.2017.01608.","journal-title":"Front. Microbiol."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/35073658","article-title":"Cellular immune responses to HIV","volume":"410","author":"McMichael A","year":"2001","unstructured":"McMichael, A., Rowland-Jones, S. Cellular immune responses to HIV. Nature 410, 980\u2013987 (2001). https:\/\/doi.org\/10.1038\/35073658.","journal-title":"Nature"},{"key":"ref39","article-title":"Isolation and analysis of mouse microglial cells","volume":"4","author":"Garcia JA","year":"2014","unstructured":"Garcia JA, Cardona SM, Cardona AE. Isolation and analysis of mouse microglial cells. Curr Protoc Immunol. 2014 Feb 4;104:14.35.1-14.35.15. doi: 10.1002\/0471142735.im1435s104. PMID: 24510618; PMCID: PMC3980480.","journal-title":"Curr Protoc Immunol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/BF00341407","author":"Yoshida Y","year":"1985","unstructured":"Yoshida Y, Ikuta F, Watabe K, Nagata T. Developmental microvascular architecture of the rat cerebellar cortex. Anat Embryol (Berl). 1985;171(2):129 \u2013 38. doi: 10.1007\/BF00341407. PMID: 3985362."},{"author":"Schmid F","key":"ref41","doi-asserted-by":"publisher","unstructured":"Schmid F, Barrett MJP, Obrist D, Weber B, Jenny P. Red blood cells stabilize flow in brain microvascular networks. PLoS Comput Biol. 2019 Aug 30;15(8):e1007231. doi: 10.1371\/journal.pcbi.1007231. PMID: 31469820; PMCID: PMC6750893.","DOI":"10.1371\/journal.pcbi.1007231"},{"author":"Stratoulias V","key":"ref42","unstructured":"Stratoulias V, Venero JL, Tremblay M\u00c8, Joseph B. Microglial subtypes: diversity within the microglial community. EMBO J. 2019 Sep 2;38(17):e101997. doi: 10.15252\/embj.2019101997. Epub 2019 Aug 2. PMID: 31373067; PMCID: PMC6717890."},{"author":"Debernardi R","key":"ref43","doi-asserted-by":"publisher","unstructured":"Debernardi R, Pierre K, Lengacher S, Magistretti PJ, Pellerin L. Cell-specific expression pattern of monocarboxylate transporters in astrocytes and neurons observed in different mouse brain cortical cell cultures. J Neurosci Res. 2003 Jul 15;73(2):141 \u2013 55. doi: 10.1002\/jnr.10660. PMID: 12836157.","DOI":"10.1002\/jnr.10660"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3934\/Neuroscience.2020007","author":"Roosterman D","year":"2020","unstructured":"Roosterman D, Cottrell GS. Astrocytes and neurons communicate via a monocarboxylic acid shuttle. AIMS Neurosci. 2020 Apr 20;7(2):94\u2013106. doi: 10.3934\/Neuroscience.2020007. PMID: 32607414; PMCID: PMC7321766."},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.2000.278.5.C921","author":"Hanu R","year":"2000","unstructured":"Hanu R, McKenna M, O'Neill A, Resneck WG, Bloch RJ. Monocarboxylic acid transporters, MCT1 and MCT2, in cortical astrocytes in vitro and in vivo. Am J Physiol Cell Physiol. 2000 May;278(5):C921-30. doi: 10.1152\/ajpcell.2000.278.5.C921. PMID: 10794666."},{"year":"2022","author":"Hamadani C","key":"ref46","unstructured":"Hamadani C, et al. Development of Ionic Liquid-Coated PLGA Nanoparticles for Applications in Intravenous Drug Delivery. Nature Protocols, 2022 (<bi>Accepted; in proof<\/bi>)."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2574352\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2574352\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T17:14:00Z","timestamp":1718990040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2574352\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,14]]},"references-count":46,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-2574352\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1002\/advs.202305484","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2023,2,14]]},"subtype":"preprint"}}